Advertisement

Topics

EuroPharma, Inc. Company Profile

07:13 EDT 23rd September 2017 | BioPortfolio


News Articles [4 Associated News Articles listed on BioPortfolio]

UMG acquires Europharma

Will attain the firm’s e-learning programmes

Orient Europharma Co Ltd 4120 Financial and Strategic SWOT Analysis Review [Report Updated: 07082017] Prices from USD $300

SummaryOrient Europharma Co Ltd Orient Europharma is a pharmaceutical company that manufactures and markets pharmaceuticals, cancer drugs, cosmeceutical, infant and adult nutrition and healthcare prod...

Orient Europharma Co Ltd 4120 Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 12052017] Prices from USD $250

SummaryOrient Europharma Co Ltd Orient Europharma is a pharmaceutical company that research, develops, manufactures and markets cancer drugs, pharmaceuticals, cosmeceutical, infant and adult nutrition...

Orient Europharma Co Ltd 4120 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummaryOrient Europharma Co Ltd Orient Europharma is a pharmaceutical company that manufactures and markets pharmaceuticals, cancer drugs, cosmeceutical, infant and adult nutrition and healthcare prod...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

More Information about "EuroPharma, Inc." on BioPortfolio

We have published hundreds of EuroPharma, Inc. news stories on BioPortfolio along with dozens of EuroPharma, Inc. Clinical Trials and PubMed Articles about EuroPharma, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of EuroPharma, Inc. Companies in our database. You can also find out about relevant EuroPharma, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record